Skip to content

Author

Mohamed Rahmani

We have 2 of 7 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Folic Acid-Conjugated Albumin-Stabilized Gold–Terbium Nanoparticles for SPCCT/MRI Imaging: An in vitro Cellular and Phantom Study

BSA@Au/Tb-FA exhibited favorable in vitro hemocompatibility and biocompatibility, with enhanced cellular uptake in MDA-MB-231 and complementary enhanced SPCCT/MRI contrast under phantom conditions, supporting its potential as a bimodal imaging agent.

Yusuf O. Ibrahim, Nabil Maalej, A. Raja et al. · 0 citations
Review Open access Aug 2026

From KRAS inhibition to tumor adaptation: mechanistic layers of resistance and therapeutic strategies.

This review synthesizes current knowledge on KRAS resistance mechanisms and highlights emerging therapeutic strategies, including rational combination approaches, enhanced RAS pathway suppression, targeted protein degradation, and KRAS-directed immunotherapies.

Rawan Salih, F. Sirajudeen, Mohamed Rahmani · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.